Kotak Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.98 ↓ -0.71%
[as on 11 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Kotak Healthcare Fund - Direct Plan - Growth Option and its peers as on 11 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Kotak Healthcare Fund - Direct Plan - Growth Option 30.76% -0.71% 1.72% 2.74% 13.82% 28.09%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.55% -0.61% -1.77% -6.48% 0.55% -13.4% 4.69% 12.12% 15.55% 13.48%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.09% -0.49% -2.13% -4.09% 3.04% -1.59% 8.1% 8.16% 13.27% 11.45%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 25.1% -0.28% 0.76% -0.34% 11.62% 21.41% 24.25% 18.68% 25.98% 14.82%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 0.9% -0.52% -0.99% -2.51% 2.23% 4.49% 13.03% 16.01% 19.85% 15.13%
SBI COMMA Fund - DIRECT PLAN - Growth 6.56% -1.27% -2.15% -0.7% 4.16% 12.2% 15.12% 11.14% 20.13% 15.56%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 42.3% -5.91%

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns -0.21% -2.26% -4.55% 7.53% -4.14% 7.75% 5.51% 7.75% 3.89% 3.63%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.07%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.73% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.27%

Equity

NameSymbol / ISINSectorWeight %Other links
SUN PHARMACEUTICAL INDUSTRIES LTD.SUNPHARMA (INE044A01036)Pharmaceuticals and Biotechnology14.88%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals and Biotechnology8.26%
TORRENT PHARMACEUTICALS LTD.TORNTPHARM (INE685A01028)Pharmaceuticals and Biotechnology6.16%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services5.15%
Ami Organics LtdACUTAAS (INE00FF01025)Pharmaceuticals and Biotechnology4.32%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals and Biotechnology4.32%
PARK MEDI WORLD LIMITED (PARK HOSPITAL)PARKHOSPS (INE119201023)Healthcare Services3.86%
Fortis Healthcare India LtdFORTIS (INE061F01013)Healthcare Services3.46%
MANKIND PHARMA LTDMANKIND (INE634S01028)Pharmaceuticals and Biotechnology3.26%
SAI LIFE SCIENCES LIMITEDSAILIFE (INE570L01029)Pharmaceuticals and Biotechnology3.08%
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTDYATHARTH (INE0JO301016)Healthcare Services2.99%
KRISHNA INSTITUTE OF MEDICALKIMS (INE967H01025)Healthcare Services2.95%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals and Biotechnology2.75%
Laurus Labs LtdLAURUSLABS (INE947Q01028)Pharmaceuticals and Biotechnology2.66%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services2.63%
ANTHEM BIOSCIENCES LTDANTHEM (INE0CZ201020)Pharmaceuticals and Biotechnology2.37%
Ajanta Pharma Ltd.AJANTPHARM (INE031B01049)Pharmaceuticals and Biotechnology2.29%
Marksans Pharma LtdMARKSANS (INE750C01026)Pharmaceuticals and Biotechnology2.27%
RUBICON RESEARCH LIMITEDRUBICON (INE506V01022)Pharmaceuticals and Biotechnology2.18%
ORCHID PHARMA LIMITEDORCHPHARMA (INE191A01027)Pharmaceuticals and Biotechnology1.88%
EMCURE PHARMACEUTICALS LIMITEDEMCURE (INE168P01015)Pharmaceuticals and Biotechnology1.87%
CORONA REMEDIES LIMITEDCORONA (INE02ZQ01018)Pharmaceuticals and Biotechnology1.85%
JUBILANT INGREVIA LTD.JUBLINGREA (INE0BY001018)Chemicals and Petrochemicals1.83%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals and Biotechnology1.62%
RAINBOW CHILDRENS MEDICARE LTDRAINBOW (INE961O01016)Healthcare Services1.56%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals and Biotechnology1.42%
JUBILANT PHARMOVA LIMITEDJUBLPHARMA (INE700A01033)Pharmaceuticals and Biotechnology1.37%
METROPOLIS HEALTHCARE LTD.METROPOLIS (INE112L01020)Healthcare Services1.28%
Zydus Lifesciences Ltd.ZYDUSLIFE (INE010B01027)Pharmaceuticals and Biotechnology1.24%
DR.Lal Pathlabs LtdLALPATHLAB (INE600L01024)Healthcare Services1.23%
INNOVA CAPTABS LTDINNOVACAP (INE0DUT01020)Pharmaceuticals and Biotechnology1.10%
LAXMI DENTAL LIMITEDLAXMIDENTL (INE0WO601020)Healthcare Equipment and Supplies0.64%
Portfolio data is as on date 31 July, 2026

NAV history

Kotak Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 September, 202617.98 -0.71%
10 September, 202618.109 0.76%
9 September, 202617.973 0.72%
8 September, 202617.845 0.56%
7 September, 202617.745 0.39%
4 September, 202617.676 -0.36%
3 September, 202617.739 0.21%
2 September, 202617.702 0.35%
1 September, 202617.64 -1.24%
31 August, 202617.862 0.4%
28 August, 202617.79 0.18%
27 August, 202617.758 0.07%
26 August, 202617.745 0.51%
25 August, 202617.655 0.84%
24 August, 202617.508 0.56%
21 August, 202617.41 0%
20 August, 202617.41 0.09%
19 August, 202617.394 -0.71%
18 August, 202617.518 0.67%
17 August, 202617.402 -0.03%
14 August, 202617.407 0.21%
13 August, 202617.371 -0.4%
12 August, 202617.44 -0.34%
11 August, 202617.5 0.36%
10 August, 202617.438 0.55%
7 August, 202617.343 0.09%
6 August, 202617.327 0.09%
5 August, 202617.311 -0.14%
4 August, 202617.335 -0.06%
3 August, 202617.345

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is 17.98 as on 11 September, 2026.
  • What are YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 30.76% as on 11 September, 2026.
  • What are 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 28.09% as on 11 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Kotak Healthcare Fund - Direct Plan - Growth Option?
    Kotak Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.